{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:56:13Z","timestamp":1791996973384,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Provincial People's Hospital, China","award":["Wjlx2022019"],"award-info":[{"award-number":["Wjlx2022019"]}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["ORF-2025-552"],"award-info":[{"award-number":["ORF-2025-552"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03384-4","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:20:00Z","timestamp":1756106400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pan-cancer analysis of PTPN6: prognostic significance and functional implications in tumor progression"],"prefix":"10.1007","volume":"16","author":[{"given":"Xiaohui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mumtaz","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qurat ul","family":"Ain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madiha","family":"Zaynab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Abdel-Maksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed N.","family":"Almana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeedah","family":"Almutair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Zomot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahidah H.","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"12","key":"3384_CR1","doi-asserted-by":"publisher","first-page":"e70045","DOI":"10.1002\/pon.70045","volume":"33","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu C, Chen X, Zhang Y, Li Y, Hu X. Effects of Web-Based acceptance and commitment therapy on Health\u2010Related outcomes among patients with lung cancer: A feasibility randomized controlled trial. Psycho\u2010Oncology. 2024;33(12):e70045.","journal-title":"Psycho\u2010Oncology"},{"key":"3384_CR2","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu Y, Song J, Liu X, Liu S, Yang N et al. Tumor cell-targeting and tumor microenvironment\u2013responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer. Int J Nanomed. 2024:5837\u201358.","DOI":"10.2147\/IJN.S466042"},{"issue":"7","key":"3384_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/cells12071002","volume":"12","author":"A Ardizzone","year":"2023","unstructured":"Ardizzone A, Bova V, Casili G, Repici A, Lanza M, Giuffrida R, et al. Role of basic fibroblast growth factor in cancer: biological activity, targeted therapies, and prognostic value. Cells. 2023;12(7):1002.","journal-title":"Cells"},{"issue":"3","key":"3384_CR4","first-page":"986","volume":"12","author":"M Usman","year":"2022","unstructured":"Usman M, Okla MK, Asif HM, AbdElgayed G, Muccee F, Ghazanfar S, et al. A pan-cancer analysis of GINS complex subunit 4 to identify its potential role as a biomarker in multiple human cancers. Am J Cancer Res. 2022;12(3):986.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"3384_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.62347\/NCPH5416","volume":"16","author":"L Huang","year":"2024","unstructured":"Huang L, Irshad S, Sultana U, Ali S, Jamil A, Zubair A, et al. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance. Am J Translational Res. 2024;16(3):873.","journal-title":"Am J Translational Res"},{"issue":"1","key":"3384_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s42003-024-06488-9","volume":"7","author":"Z Yang","year":"2024","unstructured":"Yang Z, Liu X, Xu H, Teschendorff AE, Xu L, Li J, et al. Integrative analysis of genomic and epigenomic regulation reveals MiRNA mediated tumor heterogeneity and immune evasion in lower grade glioma. Commun Biology. 2024;7(1):824.","journal-title":"Commun Biology"},{"key":"3384_CR7","doi-asserted-by":"publisher","first-page":"1482927","DOI":"10.3389\/fgene.2024.1482927","volume":"15","author":"Y Jing","year":"2024","unstructured":"Jing Y, Huang X, Wang Y, Wang J, Li Y, Yelihamu D, et al. Diagnostic value of 5 MiRNAs combined detection for breast cancer. Front Genet. 2024;15:1482927.","journal-title":"Front Genet"},{"issue":"42","key":"3384_CR8","doi-asserted-by":"publisher","first-page":"11012","DOI":"10.1039\/D4TB01367K","volume":"12","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li Z, Zhu A, Zhang Q, Zhou H, Zhou X, et al. Combined and rapid detection of anti-Brucella igg\/igm in clinical samples based on surface-enhanced Raman scattering-lateral flow immunochromatography. J Mater Chem B. 2024;12(42):11012\u201324.","journal-title":"J Mater Chem B"},{"issue":"7","key":"3384_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.21037\/tcr-23-34","volume":"12","author":"Z Luo","year":"2023","unstructured":"Luo Z, Wang Y, Bi X, Ismtula D, Wang H, Guo C. Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer. Transl Cancer Res. 2023;12(7):1765\u201386.","journal-title":"Transl Cancer Res"},{"key":"3384_CR10","doi-asserted-by":"crossref","unstructured":"Li Z, Zhu A, Zhao B, Zhang Y, Zhang Q, Zhou H et al. Establishment of a Raman nanosphere based immunochromatographic system for the combined detection of influenza A and B viruses\u2019 antigens on a single T-line. Nanotechnology. 2024;35(50).","DOI":"10.1088\/1361-6528\/ad7f61"},{"issue":"6","key":"3384_CR11","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3390\/cancers15061827","volume":"15","author":"A Ottaiano","year":"2023","unstructured":"Ottaiano A, Santorsola M, Circelli L, Trotta AM, Izzo F, Perri F, et al. Oligo-metastatic cancers: putative biomarkers, emerging challenges and new perspectives. Cancers. 2023;15(6):1827.","journal-title":"Cancers"},{"issue":"7","key":"3384_CR12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","volume":"187","author":"A Passaro","year":"2024","unstructured":"Passaro A, Al Bakir M, Hamilton EG, Diehn M, Andr\u00e9 F, Roy-Chowdhuri S, et al. Cancer biomarkers: emerging trends and clinical implications for personalized treatment. Cell. 2024;187(7):1617\u201335.","journal-title":"Cell"},{"key":"3384_CR13","doi-asserted-by":"crossref","unstructured":"Ahmad M, Khan M, Asif R, Sial N, Abid U, Shamim T et al. Expression characteristics and significant diagnostic and prognostic values of ANLN in human cancers. Int J Gen Med. 2022:1957\u201372.","DOI":"10.2147\/IJGM.S343975"},{"issue":"1","key":"3384_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.52793\/JCTR.2023.3(1)-24","volume":"3","author":"E Fadhal","year":"2023","unstructured":"Fadhal E. Unraveling the significance of signal transduction pathways: key players in cancer development and progression. J Can Ther Res. 2023;3(1):1\u20139.","journal-title":"J Can Ther Res"},{"key":"3384_CR15","doi-asserted-by":"publisher","first-page":"154736","DOI":"10.1016\/j.prp.2023.154736","volume":"249","author":"R Thapa","year":"2023","unstructured":"Thapa R, Afzal O, Gupta G, Bhat AA, Almalki WH, Alzarea SI, et al. Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer. Pathology-Research Pract. 2023;249:154736.","journal-title":"Pathology-Research Pract"},{"key":"3384_CR16","doi-asserted-by":"publisher","first-page":"129332","DOI":"10.1016\/j.ijbiomac.2024.129332","volume":"260","author":"H Yang","year":"2024","unstructured":"Yang H, Zhou H, Fu M, Xu H, Huang H, Zhong M, et al. TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt\/\u03b2-catenin signaling pathway. Int J Biol Macromol. 2024;260:129332.","journal-title":"Int J Biol Macromol"},{"key":"3384_CR17","doi-asserted-by":"crossref","unstructured":"Penafuerte C, Perez-Quintero LA, Vinette V, Hatzihristidis T, Tremblay ML. Mining the complex family of protein tyrosine phosphatases for checkpoint regulators in immunity. Emerg Concepts Target Immune Checkpoints Cancer Autoimmun. 2017:191\u2013214.","DOI":"10.1007\/82_2017_68"},{"issue":"7","key":"3384_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/pharmaceutics16070888","volume":"16","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Yao Z, Lin Y, Zhang H. From tyrosine kinases to tyrosine phosphatases: new therapeutic targets in cancers and beyond. Pharmaceutics. 2024;16(7):888.","journal-title":"Pharmaceutics"},{"issue":"18","key":"3384_CR19","doi-asserted-by":"publisher","first-page":"9822","DOI":"10.18632\/aging.205052","volume":"15","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chen J, Zhang M, Liu S, Wang T, Wu T, et al. Single-cell and bulk sequencing analyses reveal the immune suppressive role of PTPN6 in glioblastoma. Aging. 2023;15(18):9822.","journal-title":"Aging"},{"issue":"3","key":"3384_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/cells13030231","volume":"13","author":"RJ Salmond","year":"2024","unstructured":"Salmond RJ. Targeting protein tyrosine phosphatases to improve cancer immunotherapies. Cells. 2024;13(3):231.","journal-title":"Cells"},{"key":"3384_CR21","doi-asserted-by":"publisher","first-page":"1087938","DOI":"10.3389\/fgene.2022.1087938","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang J, Du Z, Huang J, Cheng Y, Yi W, et al. Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia. Front Genet. 2023;13:1087938.","journal-title":"Front Genet"},{"issue":"3","key":"3384_CR22","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3390\/cimb46030156","volume":"46","author":"M Di Crosta","year":"2024","unstructured":"Di Crosta M, Arena A, Benedetti R, Gilardini Montani MS, Cirone M. 5-AZA upregulates SOCS3 and PTPN6\/SHP1, inhibiting STAT3 and potentiating the effects of AG490 against primary effusion lymphoma cells. Curr Issues Mol Biol. 2024;46(3):2468\u201379.","journal-title":"Curr Issues Mol Biol"},{"issue":"12","key":"3384_CR23","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/biom10121659","volume":"10","author":"S Mcheik","year":"2020","unstructured":"Mcheik S, Aptecar L, Coopman P, D\u2019hondt V, Freiss G. Dual role of the PTPN13 tyrosine phosphatase in cancer. Biomolecules. 2020;10(12):1659.","journal-title":"Biomolecules"},{"key":"3384_CR24","unstructured":"Wu S, Sun L, Jin P, Zhang J, Liu W, Zhan Z et al. Pan-cancer analysis revealing that PTPN2 is a indicator of risk stratification for acute myeloid leukemia identification of high-risk patients. 2023."},{"issue":"2","key":"3384_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.52243\/bptjm.v3i2.49","volume":"3","author":"H Yishak","year":"2023","unstructured":"Yishak H, Halwah K, Rhim J. Exploring the therapeutic potential of PTPN families in lung and digestive cancers. Berkeley Pharma Tech J Med. 2023;3(2):82\u2013100.","journal-title":"Berkeley Pharma Tech J Med"},{"issue":"7","key":"3384_CR26","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4103\/jcrt.jcrt_1902_21","volume":"19","author":"Y Hameed","year":"2023","unstructured":"Hameed Y. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses. J Cancer Res Ther. 2023;19(7):1852\u201364.","journal-title":"J Cancer Res Ther"},{"issue":"8","key":"3384_CR27","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1007\/s12035-023-03911-w","volume":"61","author":"X Wu","year":"2024","unstructured":"Wu X, Fu M, Ge C, Zhou H, Huang H, Zhong M, et al. m6A-Mediated upregulation of LncRNA CHASERR promotes the progression of glioma by modulating the miR-6893-3p\/TRIM14 axis. Mol Neurobiol. 2024;61(8):5418\u201340.","journal-title":"Mol Neurobiol"},{"key":"3384_CR28","doi-asserted-by":"crossref","unstructured":"Huang B, An H, Chu J, Ke S, Ke J, Qiu Y et al. Glucose-Responsive and analgesic gel for diabetic subcutaneous abscess treatment by simultaneously boosting photodynamic therapy and relieving hypoxia. Adv Sci. 2025:e02830.","DOI":"10.1002\/advs.202502830"},{"key":"3384_CR29","doi-asserted-by":"crossref","unstructured":"Cheng Y, Wang L, Zhang S, Jian W, Zeng B, Liang L et al. The investigation of Nf\u03bab inhibitors to block cell proliferation in OSCC cells lines. Curr Med Chem. 2024.","DOI":"10.2174\/0109298673309489240816063313"},{"key":"3384_CR30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jconrel.2024.11.064","volume":"377","author":"F Du","year":"2025","unstructured":"Du F, Ye Z, He A, Yuan J, Su M, Jia Q, et al. An engineered \u03b11\u03b21 integrin-mediated Fc\u03b3RI signaling component to control enhanced CAR macrophage activation and phagocytosis. J Controlled Release. 2025;377:689\u2013703.","journal-title":"J Controlled Release"},{"key":"3384_CR31","doi-asserted-by":"publisher","first-page":"115937","DOI":"10.1016\/j.jpba.2023.115937","volume":"240","author":"Y Lou","year":"2024","unstructured":"Lou Y, Cheng M, Cao Q, Li K, Qin H, Bao M, et al. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS\/MS and its application in the clinical determination in patients with tumors associated with overactive bladder. J Pharm Biomed Anal. 2024;240:115937.","journal-title":"J Pharm Biomed Anal"},{"issue":"W1","key":"3384_CR32","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"3384_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"11","key":"3384_CR34","first-page":"6464","volume":"15","author":"MA Abdel-Maksoud","year":"2023","unstructured":"Abdel-Maksoud MA, Ullah S, Nadeem A, Khan QUA, Zia MK, Ali S, et al. PTPN3 in cancer: unveiling its immune-mediated impact on prognosis and dysregulated signaling pathways. Am J Translational Res. 2023;15(11):6464.","journal-title":"Am J Translational Res"},{"issue":"W1","key":"3384_CR35","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3384_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 2018;27(1):233\u201344.","journal-title":"Protein Sci"},{"issue":"D1","key":"3384_CR37","doi-asserted-by":"publisher","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","volume":"50","author":"G Tang","year":"2022","unstructured":"Tang G, Cho M, Wang X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 2022;50(D1):D1334\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"3384_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"20","key":"3384_CR39","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200\u20132.","journal-title":"Bioinformatics"},{"issue":"D1","key":"3384_CR40","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47(D1):D900\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3384_CR41","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3384_CR42","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"key":"3384_CR43","doi-asserted-by":"crossref","unstructured":"Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y et al. GSCA: an integrated platform for gene set cancer analysis at genomic, Pharmacogenomic and Immunogenomic levels. Brief Bioinform. 2023;24(1).","DOI":"10.1093\/bib\/bbac558"},{"key":"3384_CR44","doi-asserted-by":"crossref","unstructured":"Mazingi D, Lakhoo K. Cancer Development and Progression and the Hallmarks of Cancer. Pediatric Surgical Oncology: Springer; 2023. pp. 1\u201315.","DOI":"10.1007\/978-3-030-71113-9_23-1"},{"issue":"12","key":"3384_CR45","first-page":"5721","volume":"27","author":"L Ermini","year":"2023","unstructured":"Ermini L, Taurone S, Greco A, Artico M. Cancer progression: a single cell perspective. Eur Rev Med Pharmacol Sci. 2023;27(12):5721\u201347.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"3384_CR46","first-page":"2591","volume":"16","author":"Y Dong","year":"2024","unstructured":"Dong Y, Wu X, Xu C, Hameed Y, Abdel-Maksoud MA, Almanaa TN, et al. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures. Aging. 2024;16(3):2591.","journal-title":"Aging"},{"issue":"3","key":"3384_CR47","doi-asserted-by":"publisher","first-page":"940","DOI":"10.62347\/QNNE5428","volume":"16","author":"M Luo","year":"2024","unstructured":"Luo M, Rehman A, Haque S, Izhar S, Perveen F, Haris M, et al. Thorough examination of the potential biological implications of the cuproptosis-related gene LIPT2 in the prognosis and immunotherapy in pan-cancer. Am J Translational Res. 2024;16(3):940.","journal-title":"Am J Translational Res"},{"issue":"1","key":"3384_CR48","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1038\/s41598-025-85444-x","volume":"15","author":"F Luan","year":"2025","unstructured":"Luan F, Cui Y, Huang R, Yang Z, Qiao S. Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM. Sci Rep. 2025;15(1):3223.","journal-title":"Sci Rep"},{"issue":"1","key":"3384_CR49","doi-asserted-by":"publisher","first-page":"25331","DOI":"10.1038\/s41598-024-76798-9","volume":"14","author":"Z Cao","year":"2024","unstructured":"Cao Z, Zhu J, Wang Z, Peng Y, Zeng L. Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses. Sci Rep. 2024;14(1):25331.","journal-title":"Sci Rep"},{"key":"3384_CR50","doi-asserted-by":"publisher","first-page":"113392","DOI":"10.1016\/j.intimp.2024.113392","volume":"144","author":"D-Y Sun","year":"2025","unstructured":"Sun D-Y, Hu Y-J, Li X, Peng J, Dai Z-J, Wang S. Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies. Int Immunopharmacol. 2025;144:113392.","journal-title":"Int Immunopharmacol"},{"key":"3384_CR51","doi-asserted-by":"crossref","unstructured":"Bin T, Tang J, Lu B, Xu X-J, Lin C, Wang Y. Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi-associated genes. Ann Hematol. 2024:1\u201318.","DOI":"10.1007\/s00277-024-06119-7"},{"key":"3384_CR52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.25259\/Cytojournal_165_2024","volume":"21","author":"M Xiao","year":"2024","unstructured":"Xiao M, Zhou J, Zhang W, Ding Y, Guo J, Liang X, et al. Association of immunosuppressive CD45\u2009+\u2009CD33\u2009+\u2009CD14\u2009\u2013\u2009CD10\u2009\u2013\u2009HLA-DR\u2013\/low neutrophils with poor prognosis in patients with lymphoma and their expansion and activation through STAT3\/arginase-1 pathway in vitro. CytoJournal. 2024;21:69.","journal-title":"CytoJournal"},{"issue":"6","key":"3384_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41577-023-00973-8","volume":"24","author":"LH Butterfield","year":"2024","unstructured":"Butterfield LH, Najjar YG. Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations. Nat Rev Immunol. 2024;24(6):399\u2013416.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3384_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41065-025-00369-9","volume":"162","author":"F Jiang","year":"2025","unstructured":"Jiang F, Ahmad S, Kanwal S, Hameed Y, Tang Q. Key wound healing genes as diagnostic biomarkers and therapeutic targets in uterine corpus endometrial carcinoma: an integrated in Silico and in vitro study. Hereditas. 2025;162(1):5.","journal-title":"Hereditas"},{"issue":"2","key":"3384_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/1566524022666220112142409","volume":"23","author":"M Usman","year":"2023","unstructured":"Usman M, Hameed Y, Ahmad M, Iqbal MJ, Maryam A, Mazhar A, et al. SHMT2 is associated with tumor purity, CD8\u2009+\u2009T immune cells infiltration, and a novel therapeutic target in four different human cancers. Curr Mol Med. 2023;23(2):161\u201376.","journal-title":"Curr Mol Med"},{"issue":"9","key":"3384_CR56","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.1007\/s11033-021-06635-z","volume":"48","author":"NM Abdel-Hamid","year":"2021","unstructured":"Abdel-Hamid NM, Abass SA. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting. Mol Biol Rep. 2021;48(9):6525\u201338.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"3384_CR57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/path.4586","volume":"237","author":"GT Brown","year":"2015","unstructured":"Brown GT, Murray GI. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 2015;237(3):273\u201381.","journal-title":"J Pathol"},{"issue":"3","key":"3384_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2023.8485","volume":"49","author":"Y-L Chen","year":"2023","unstructured":"Chen Y-L, Hsieh C-C, Chu P-M, Chen J-Y, Huang Y-C, Chen C-Y. Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression. Oncol Rep. 2023;49(3):1\u201311.","journal-title":"Oncol Rep"},{"key":"3384_CR59","doi-asserted-by":"crossref","unstructured":"Wang A, Zhang Y, Lv X, Liang G. Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases. Acta Pharm Sinica B. 2024.","DOI":"10.1016\/j.apsb.2024.05.006"},{"key":"3384_CR60","doi-asserted-by":"crossref","unstructured":"Xie L, Qi H, Tian W, Bu S, Wu Z, Wang H. High-expressed PTPN1 promotes tumor proliferation signature in human hepatocellular carcinoma. Heliyon. 2023;9(9).","DOI":"10.1016\/j.heliyon.2023.e19895"},{"issue":"1","key":"3384_CR61","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/ijms25010331","volume":"25","author":"S Lim","year":"2023","unstructured":"Lim S, Lee KW, Kim JY, Kim KD. Consideration of SHP-1 as a molecular target for tumor therapy. Int J Mol Sci. 2023;25(1):331.","journal-title":"Int J Mol Sci"},{"key":"3384_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-1086-5","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Zhao X, Yuan Y, Jing J-J. The expression patterns and the diagnostic\/prognostic roles of PTPN family members in digestive tract cancers. Cancer Cell Int. 2020;20:1\u201315.","journal-title":"Cancer Cell Int"},{"key":"3384_CR63","doi-asserted-by":"publisher","first-page":"805311","DOI":"10.3389\/fimmu.2022.805311","volume":"13","author":"W Kuang","year":"2022","unstructured":"Kuang W, Wang X, Ding J, Li J, Ji M, Chen W, et al. PTPN2, A key predictor of prognosis for pancreatic adenocarcinoma, significantly regulates cell cycles, apoptosis, and metastasis. Front Immunol. 2022;13:805311.","journal-title":"Front Immunol"},{"key":"3384_CR64","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1007\/s13277-013-1590-5","volume":"35","author":"L Sooman","year":"2014","unstructured":"Sooman L, Ekman S, Tsakonas G, Jaiswal A, Navani S, Edqvist P-H, et al. PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas. Tumor Biology. 2014;35:4479\u201388.","journal-title":"Tumor Biology"},{"key":"3384_CR65","doi-asserted-by":"publisher","first-page":"114545","DOI":"10.1016\/j.intimp.2025.114545","volume":"154","author":"B Liu","year":"2025","unstructured":"Liu B, Li C, He S, Li Z, Wang H, Feng C, et al. Ubiquitin-conjugating enzyme E2S (UBE2S) as a prognostic biomarker and regulator of tumorigenesis in osteosarcoma. Int Immunopharmacol. 2025;154:114545.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3384_CR66","doi-asserted-by":"publisher","first-page":"18372","DOI":"10.1038\/s41598-023-44892-z","volume":"13","author":"X Wang","year":"2023","unstructured":"Wang X, Wu S, Sun L, Jin P, Zhang J, Liu W, et al. Pan-cancer analysis revealing that PTPN2 is an indicator of risk stratification for acute myeloid leukemia. Sci Rep. 2023;13(1):18372.","journal-title":"Sci Rep"},{"key":"3384_CR67","doi-asserted-by":"crossref","unstructured":"Chen J, Zhao X, Yuan Y, Jing J. -j. The expression patterns and the prognostic roles of PTPN family members in digestive tract cancers. 2020.","DOI":"10.21203\/rs.3.rs-19689\/v1"},{"issue":"1","key":"3384_CR68","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","volume":"40","author":"H Zhang","year":"2021","unstructured":"Zhang H, Dai Z, Wu W, Wang Z, Zhang N, Zhang L, et al. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer. J Experimental Clin Cancer Res. 2021;40(1):184.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"2","key":"3384_CR69","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.18632\/oncotarget.13895","volume":"8","author":"Y Dong","year":"2016","unstructured":"Dong Y, Sun Q, Zhang X. PD-1 and its ligands are important immune checkpoints in cancer. Oncotarget. 2016;8(2):2171.","journal-title":"Oncotarget"},{"key":"3384_CR70","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.3389\/fimmu.2018.02504","volume":"9","author":"KA Pike","year":"2018","unstructured":"Pike KA, Tremblay ML. Protein tyrosine phosphatases: regulators of CD4 T cells in inflammatory bowel disease. Front Immunol. 2018;9:2504.","journal-title":"Front Immunol"},{"key":"3384_CR71","doi-asserted-by":"publisher","first-page":"682435","DOI":"10.3389\/fimmu.2021.682435","volume":"12","author":"Z Wu","year":"2021","unstructured":"Wu Z, Li S, Zhu X. The mechanism of stimulating and mobilizing the immune system enhancing the anti-tumor immunity. Front Immunol. 2021;12:682435.","journal-title":"Front Immunol"},{"key":"3384_CR72","doi-asserted-by":"crossref","unstructured":"Cen K, Zhou J, Lv G, Zhu H, Guo Y, Zhang H. Construction of a new prognosis prediction model and immune infiltration analysis of bladder urothelial cancer based on disulfidptosis-related immune genes. 2024.","DOI":"10.21203\/rs.3.rs-4389522\/v1"},{"issue":"180","key":"3384_CR73","doi-asserted-by":"publisher","first-page":"113","DOI":"10.24976\/Discov.Med.202436180.10","volume":"36","author":"T Xing","year":"2024","unstructured":"Xing T, Chen J, Ding J, Liu J, Ling S, Luo Y. CircRNA hsa_circ_0120175 promotes ovarian cancer tumorigenesis and predicts a poor prognosis. Discov Med. 2024;36(180):113\u201320.","journal-title":"Discov Med"},{"key":"3384_CR74","doi-asserted-by":"crossref","unstructured":"Sun W, Jang M-S, Zhan S, Liu C, Sheng L, Lee JH et al. Tumor-targeting and redox-responsive photo-cross-linked nanogel derived from multifunctional hyaluronic acid-lipoic acid conjugates for enhanced in vivo protein delivery. Int J Biol Macromol. 2025:144444.","DOI":"10.1016\/j.ijbiomac.2025.144444"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03384-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03384-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:33:52Z","timestamp":1757424832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03384-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3384"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03384-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1611"}}